跳至主要内容
临床试验/NCT01577576
NCT01577576终止不适用

Morphological, Biomechanical and Functional Properties of the Arterial Wall of Athletes: Impact and Consequences of Mechanical Stress on the Cardiovascular Adaptations of Peripheral Arterial Calcifications

Centre Hospitalier Universitaire de Nīmes2 个研究点 分布在 1 个国家目标入组 56 人开始时间: 2012年9月最近更新:
适应症

试验速览

阶段
不适用
状态
终止
发起方
入组人数
56
试验地点
2
主要终点
Presence / absence of intra parietal calcification of lower limb arteries

研究概览

简要总结

The main objective of this study is to obtain data for the integrated analysis of morphological, functional and biomechanical parameters pertaining to lower limb arteries in various categories of elite athletes (without cardiovascular risk and practicing high- or low-impact aerobic activities which preferentially implicate lower limb activity) as compared to (each other and to) sedentary controls.

详细描述

Secondary objectives of this study are:

A. Determine the presence and extent of intima-media calcifications in athletes B. Determine the relationship between these calcifications and the level, length and intensity of sports activity.

C. Determine the relationship between these properties and calcification of the arterial wall D. Analyze the relationship between the type of sports activity and properties of the arterial wall.

E. Examine the relationship between the properties of the arterial wall and peripheral perfusion pressures.

F. Examine the relationship between the properties of the arterial wall, changes in afterload, morphology and systolic heart function.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Cross Sectional

入排标准

年龄范围
25 Years 至 40 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

结局指标

主要结局

Presence / absence of intra parietal calcification of lower limb arteries

时间窗: Baseline (Day 0; transversal study)

次要结局

  • Extent of intra parietal calcification of lower limb arteries(Baseline (Day 0; transversal study))
  • Inner diameter of the intima-media of the superficial femoral artery (mm)(Baseline (Day 0; transversal study))
  • Outer diameter of the intima-media of the superficial femoral artery (mm)(Baseline (Day 0; transversal study))
  • Inner diameter of the intima-media of the common carotid artery (mm)(Baseline (Day 0; transversal study))
  • Inner diameter of the intima-media of the common femoral artery (mm)(Baseline (Day 0; transversal study))
  • Outer diameter of the intima-media of the common femoral artery (mm)(Baseline (Day 0; transversal study))
  • Compliance of the carotid artery(Baseline (Day 0; transversal study))
  • Outer diameter of the intima-media of the common carotid artery (mm)(Baseline (Day 0; transversal study))
  • Thickness of the intima-media of the common femoral artery (mm)(Baseline (Day 0; transversal study))
  • Thickness of the intima-media of the superficial femoral artery (mm)(Baseline (Day 0; transversal study))
  • Thickness of the intima-media of the common carotid artery (mm)(Baseline (Day 0; transversal study))
  • Local parietal compliance of the superficial femoral artery(Baseline (Day 0; transversal study))
  • Distensibility of the carotid artery(Baseline (Day 0; transversal study))
  • Arterial wave velocity in upper limb(Baseline (Day 0; transversal study))
  • Endothelium-dependent vasorelaxation in the femoral artery(Baseline (Day 0; transversal study))
  • Postischemic vasomotor response at the (skin) microcirculatory level(Baseline (Day 0; transversal study))
  • Systolic pressure index at the ankle(Baseline (Day 0; transversal study))
  • Cardiac afterload index(Baseline (Day 0; transversal study))
  • Arterial wave velocity in lower limb(Baseline (Day 0; transversal study))
  • Systolic pressure index for the big toe(Baseline (Day 0; transversal study))
  • Echocardiographic parameters analyzing systolic function: the stroke volume(Baseline (Day 0; transversal study))
  • Echocardiographic parameters analyzing diastolic function: transmitral A wave velocity(Baseline (Day 0; transversal study))
  • Echocardiographic parameters analyzing systolic function: cardiac output(Baseline (Day 0; transversal study))
  • Echocardiographic parameters analyzing diastolic function: early diastolic strain-rate(Baseline (Day 0; transversal study))
  • Echocardiographic parameters analyzing systolic function: peripheral vascular resistance(Baseline (Day 0; transversal study))
  • Echocardiographic parameters analyzing systolic function: fractional shortening(Baseline (Day 0; transversal study))
  • Echocardiographic parameters analyzing systolic function: global longitudinal strain(Baseline (Day 0; transversal study))
  • Ventricular-arterial coupling(Baseline (Day 0; transversal study))
  • Echocardiographic parameters analyzing diastolic function: transmitral E wave velocity(Baseline (Day 0; transversal study))
  • Echocardiographic parameters analyzing systolic function: speed of the S-wave according to tissue Doppler(Baseline (Day 0; transversal study))
  • Echocardiographic parameters analyzing diastolic function: transmitral E wave velocity / transmitral A wave velocity(Baseline (Day 0; transversal study))
  • Echocardiographic parameters analyzing diastolic function: maximum Em wave velocity according to tissue Doppler(Baseline (Day 0; transversal study))
  • Echocardiographic parameters analyzing diastolic function: maximum Am wave velocity according to tissue Doppler(Baseline (Day 0; transversal study))
  • Echocardiographic parameters analyzing diastolic function: transmitral E wave velocity / maximum Em wave velocity according to tissue Doppler(Baseline (Day 0; transversal study))
  • Years of athletic training(Baseline (Day 0; transversal study))
  • Best performance in the last 6 months(Baseline (Day 0; transversal study))
  • Hours of athletic training per week(Baseline (Day 0; transversal study))
  • Lower limb muscle mass(Baseline (Day 0; transversal study))
  • Bone density(Baseline (Day 0; transversal study))
  • Dietary calcium intake(Baseline (Day 0; transversal study))
  • Dietary protein intake(Baseline (Day 0; transversal study))
  • Serum protein(Baseline (Day 0; transversal study))
  • Serum parathyroid hormone(Baseline (Day 0; transversal study))
  • Serum calcium(Baseline (Day 0; transversal study))
  • Serum phosphorus(Baseline (Day 0; transversal study))
  • Serum vitamin D2(Baseline (Day 0; transversal study))
  • Serum vitamin D3(Baseline (Day 0; transversal study))

研究者

发起方
Centre Hospitalier Universitaire de Nīmes
申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验